All posts by Bob Hyde

Bob Hyde founded the Kings Private Clinic Group. In the early 1980s he decided it was time for a change so with a doctor friend started what is now the Kings Private Clinic Group. His involvement in the Group over the last 32 years was extensive. Bob Hyde Google +

Weight Loss Surgery Makes Food Less Desirable for Patients

Amazing new scientific discovery shows that after weight loss surgery you become less attracted to food.

American scientists have recently discovered a correlation between bariatric weight loss surgery and the patients’ interest in food. The scientists looked at brain scans from 16 patients who underwent weight loss surgery and 15 others who lost weight through dieting.

The group who underwent surgery to have gastric bands fitted were shown to have less interest in food. The study also found that weight loss surgery per se contributed to the patient’s brain being ‘re-wired’ to find food less desirable.

MRI examinations found that the brain was reacting to images of appetising food such as pizza, differently depending on which method of weight loss had been used. The ground-breaking study was conducted at the University of Missouri-Kansas City.

The study concluded that food means a lot more to people who lose weight via conventional means as opposed to those who undergo weight loss surgery.

Start Your Weight Loss Journey Today!

Get in touch today for a free consultation with a weight loss specialist.

Quick contact form

    Start Your Weight Loss Journey Today!

    Full name: (required)

    Your email: (required)

    Your telephone:

    Choose your nearest clinic:

    Additional comments:

    Email us: kingsweightloss@gmail.com
    Call us: 0208 597 4321

    Amanda Bruce, psychologist at the University of Missouri-Kansas City and the University of Kansas School of Medicine had this to say:

    ‘They’re not as interested in eating,’ ‘They’re not as motivated by food.’

    She also went on to say:

    ‘A huge strength of this paper is that the people in the two different groups were a match on the weight that they had lost,’

    Weight Loss Campaign ‘Lose a Little, Keep it Off Backed By NHS

    The NHS has now backed ‘NICE’ campaign to encourage overweight and obese people to lose a few pounds.

    Recently the National Institute for Health and Care Excellence (NICE) has released new weight loss guidelines for managing overweight and obesity in adults. NICE would like to see obese and overweight adults take up slimming classes with the aim of losing at least 3% of their body weight.

    [one_half]

    Statistics have shown that 2 in 3 adults in England have a BMI higher than 25. This puts them into the overweight category and above with a BMI of 30 or over meaning you are obese.

    NHS GP’s have been told they need to raise any weight related issues in a “respectful and non-judgmental” and to identify people eligible for referral to weight loss programmes.

    Ditch the yo-yo…yo!

    Professor Mike Kelly Public Health Centre Director for NICE spoke about the issued guidelines being about lifelong change as opposed to yo-yo dieting. Yo-yo dieting is where your weight goes up and down consecutively.

    [/one_half]

    [one_half_last]

    [box style=”2″]

    Basic obesity statistics

    [list]
    [list_item icon=”ok”]One in 4 adults in England obese[/list_item]
    [list_item icon=”ok”]A further 42% of men are classed as overweight[/list_item]
    [list_item icon=”ok”]The figure for women in 32%[/list_item]
    [list_item icon=”ok”]A BMI of 30-35 cuts life expectancy by up to four years[/list_item]
    [list_item icon=”ok”]A BMI of 40 or more cuts life expectancy by up to 10 years[/list_item]
    [list_item icon=”ok”]Obesity costs NHS £5.1bn a year[/list_item]

    [/list]

    Source: National Institute of Health and Care Excellence

    [/box][/one_half_last]

    Start Your Weight Loss Journey Today!

    Get in touch today for a free consultation with a weight loss specialist.

    Quick contact form

      Start Your Weight Loss Journey Today!

      Full name: (required)

      Your email: (required)

      Your telephone:

      Choose your nearest clinic:

      Additional comments:

      Email us: kingsweightloss@gmail.com
      Call us: 0208 597 4321

      Professor Kelly said required achievable goals are needed:

      We would like to offer an instant solution and a quick win, a much greater ambition if you like, but realistically it’s important to bear in mind this is difficult. People find it difficult to do – it’s not something you can just wake up one morning and decide I’m going to lose 10 pounds, it takes resolve, it takes encouragement.

      Demonstrable weight loss

      NICE has also indicated that providers of weight management programmes need to ensure that patients and participants engage in demonstrable weight loss maintenance for at least 12 months and more.

      NICE did acknowledge the many difficulties that overweight and obese people face saying there was “no magic bullet” that could solve the problem.

      Sir Richard Thompson, the president of the Royal College of Physicians, said:

      “The majority of Britain is expected to be obese by 2050.”

      New UK Weight Loss Study Shows Frequent Eating Complete Myth

      Small and often has been a weight loss mantra for as long as we can remember. However this idea was recently exposed as the myth it is by a study carried out by the UK University of Warwick.

      The study found that eating small meals frequently does not encourage weight loss or (as was once thought) provide a boost to the body’s metabolism. What was discovered was the ultimately healthy weight loss all comes down to counting the calories.

      The UK researchers examined and studied 24 obese and lean females on separate days. The women were given either 2 or 5 meals over a 24 hour period which consisted of the same amount of calories to be consumed inside the 24 hour period. Test conducted at the end of each day revealed that the obese women eating 5 smaller meals actually ‘accumulated significantly higher levels of endotoxins’ than the women eating only 2 meals a day.

      Start Your Weight Loss Journey Today!

      Get in touch today for a free consultation with a weight loss specialist.

      Quick contact form

        Start Your Weight Loss Journey Today!

        Full name: (required)

        Your email: (required)

        Your telephone:

        Choose your nearest clinic:

        Additional comments:

        Email us: kingsweightloss@gmail.com
        Call us: 0208 597 4321

        The researchers were looking for evidence on whether the consumption of multiple meals could expose an obese patient to increased risk of type 2 diabetes and cardiovascular disease. In previously conducted studies it has been shown that eating a high fat meal can cause low-level inflammation. It’s that low-level inflammation that has been shown to be linked to type 2 diabetes and cardiovascular disease.

        Dr. Piya says their weight loss research has yielded two main findings:

        “Firstly, that the size or frequency of the meal doesn’t affect the calories we burn in a day, but what matters most for losing weight is counting calories. Secondly, by carrying more weight, more endotoxin enters the circulation to cause inflammation, and eating more often will exacerbate this risk, which has been linked to metabolic diseases such as type-2 diabetes.”

        The weight loss research was presented at the Society for Endocrinology annual BES conference in Liverpool.

        Is Seaweed the New Obesity Tidal Flood Quick Fix?

        The BBC has recently reported that a new study suggests that seaweed (alginates) could be a key factor in helping weight loss through blocking fat absorption.

        Researchers from Newcastle University in the UK have recently conducted a study into the alginates that naturally occur in seaweed or kelp to be specific. The research conducted has discovered that these alginates may be able to help reduce fat absorption in the human body. The study was published in the peer-reviewed science journal Food Chemistry.

        The study centred around specific types of alginates that have been shown to slow down the activity of the pancreatic lipase which is a fat digesting enzyme.

        The end result, if successful would mean the partial blockage of the volume of fat absorbed by the human body which of course could help significantly with obesity problems.

        Fat blockers not entirely healthy.

        Generally it is accepted in the medical profession that fats are important to human digestion. The problem of course lies in excessive fat consumption and the absorption of it.

        Clearly anything that inhibits the body’s natural capacity to absorb fat will have some consequences as the fat has to go somewhere. There are weight loss drugs such as Orlistat which essentially function using the same principle but result in side effects such as flatulence and oily diarrhoea.

        So it is pretty clear that taking a substance that decreases fat absorption will never be a suitable replacement for a healthy diet and regular exercise. Not only that, it may even encourage excess consumption and a decrease in diet quality in some patients.

        Irrespective of any findings the weight loss market is rife with ‘quick-fix’ weight loss treatments based around seaweed. The excess fat is passed through the system and doesn’t accumulate under the skin or around your vital organs which is the cause of health issues.

        Alginates – a quick rundown.

        Alginic acid which is also called algin or alginate is an anionic polysaccharide found in the cell walls of brown seaweeds. Alginates are refined from these brown seaweeds with a wide variety of brown seaweeds being harvested throughout the world.

        The Alginates are then converted into sodium alginate which is what is used the food and pharmaceutical industries. In the food industry they are used as gelling agents and thickeners to alter and improve food texture.

        New Weight Loss Pills Qsymia Wins Approval

        Recently a new weight-loss pill by the name of Qsymia has gotten the approval of the American Food and Drug Administration. Many doctors consider Qsymia the most effective in a new generation of of obesity drugs. Qsymia has been approved for people who are overweight or considered obese and have an overweight related condition such as diabetes or high blood pressure.

        There is hope that this new drug will succeed where others have in the past failed and has highlighted the intense difficulty for drug companies to produce successful and safe drugs in the weight loss category. Qsymia is produced by Vivus Inc who are to have said that it will release the drug in the 4th quarter with the price set to be announced soon after.

        Start Your Weight Loss Journey Today!

        Get in touch today for a free consultation with a weight loss specialist.

        Quick contact form

          Start Your Weight Loss Journey Today!

          Full name: (required)

          Your email: (required)

          Your telephone:

          Choose your nearest clinic:

          Additional comments:

          Email us: kingsweightloss@gmail.com
          Call us: 0208 597 4321

          Impressive Weight Loss Pills Clinical Trials.

          The drug was tested very successfully with patients experiencing more weight loss than the other 2 weight loss pills that were tested. In one study those patients taking Qsymia lost 6.7% of their body weight whilst in another trial patients lost 8.9% of their body weight. The best result was a patient losing 11% of their body weight whilst taking the strongest dose.

          Qsymia has had quite impressive trials despite it not being a completely new scientific breakthrough. Qsymia is a combination of Phentermine and Tapirimate, 2 drugs which are already on the market. Topiramate is sold by Johnson & Johnson as Topamax and is used as an anticonvulsant whereas Phentermine is an appetite surpressant and has been used for short term weight loss.

          The American Food and Drug Administration’s approval of Qsymia weight loss pills has been interpreted as a new willingness to make available new weight loss drugs. Qsymia was initially rejected in 2010 because of concerns over birth defects when taken during pregnancy however this time around it has introduced a risk management plan to minimise any risks during pregnancy.

          With a relatively small launch planned, execs will be focussing on weight loss specialists and not general doctors. The release date for the UK is unknown.